ALXO
Alx Oncology Holdings Inc
$14.49
Earnings Summary
Revenue | $0Mn |
Net Profits | $-45.47Mn |
Net Profit Margins | -Inf% |
Highlights
Alx Oncology Holdings Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Alx Oncology Holdings Inc has generated NaN% jump in its revenue since last 3-months.
Alx Oncology Holdings Inc’s net profit fell -48.07% since last year same period to $-45.47Mn in the Q4 2023. On a quarterly growth basis, Alx Oncology Holdings Inc has generated 10.82% jump in its net profits since last 3-months.
Alx Oncology Holdings Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Alx Oncology Holdings Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Alx Oncology Holdings Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.84 |
EPS Estimate Current Year | -0.84 |
Highlights
Alx Oncology Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.84 - a 0% jump from last quarter’s estimates.
Alx Oncology Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.84.
Key Ratios
Key ratios of the Alx Oncology Holdings Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.93 |
Highlights
Alx Oncology Holdings Inc’s earning per share (EPS) fell -24% since last year same period to -0.93 in the Q4 2023. This indicates that the Alx Oncology Holdings Inc has generated -24% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-11 | -0.8 | -0.74 | 7.5% |
2023-11-13 | -0.87 | -1.24 | -42.53% |
2024-03-07 | -0.84 | -0.93 | -10.71% |
2023-08-10 | -0.88 | -0.84 | 4.55% |
₹0 US Stocks a/c Opening Fee